Selective inhibition of LY294002 across cloned human cardiac ion channels: implications for atrium-selective therapy in atrial fibrillation
- DOI
- 10.3389/fphar.2026.1899932
- Published
- 2026-09-09
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1899932,
title = {Selective inhibition of LY294002 across cloned human cardiac ion channels: implications for atrium-selective therapy in atrial fibrillation},
author = {Rui Niu and Jiawei Li and Huanle Fang and Wei Zhao and Chao Dong and Ningjuan Han and Mengyuan Chen and Lie Ma and Liang Li and Yun Fan and Bing Zhu and Beibei Bie and Jie Wu and Hiroshi Matsuura and Minoru Horie},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1899932},
url = {https://doi.org/10.3389/fphar.2026.1899932}
}RIS
TY - JOUR TI - Selective inhibition of LY294002 across cloned human cardiac ion channels: implications for atrium-selective therapy in atrial fibrillation AU - Rui Niu AU - Jiawei Li AU - Huanle Fang AU - Wei Zhao AU - Chao Dong AU - Ningjuan Han AU - Mengyuan Chen AU - Lie Ma AU - Liang Li AU - Yun Fan AU - Bing Zhu AU - Beibei Bie AU - Jie Wu AU - Hiroshi Matsuura AU - Minoru Horie PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1899932 UR - https://doi.org/10.3389/fphar.2026.1899932 ER -
APA
Niu, R., Li, J., Fang, H., Zhao, W., Dong, C., Han, N., Chen, M., Ma, L., Li, L., Fan, Y., Zhu, B., Bie, B., Wu, J., Matsuura, H., & Horie, M. (2026). Selective inhibition of LY294002 across cloned human cardiac ion channels: implications for atrium-selective therapy in atrial fibrillation. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1899932
Source records
- crossref · retrieved 2026-09-25T03:32:19.107Z